The USPTO asks the Fed. Circ. Not to comment on the power of Hirshfeld
By Britain Eakin (May 17, 2022, 5:56 p.m. EDT) — The U.S. Patent and Trademark Office on Tuesday urged the Federal Circuit not to rule on whether the former acting director was allowed to review decisions of the Patent Trial and Appeals Board under the United States Supreme Court’s Arthrex Decision, marking the latest development in the ongoing Arthrex saga.
In a motion for a limited remand, the agency asked the appeals court to remand the case to the agency to allow newly-confirmed USPTO director Kathi Vidal to decide whether to review or not a 2018 PTAB decision that killed Arthrex Inc.’s medical implant device patent in a challenge from Smith & Nephew Inc. Drew…
Stay one step ahead
In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.
Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and more!